Skip to content

Clinical trial to evaluate the efficacy of Shiroabhyanga with Ksheerabala taila in the management of Nidranash

Randomized Clinical trial to evaluate the efficacy of Shiroabhyanga with Ksheerabala taila in the management of Nidranash w.s.r to Insomnia - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084450
Enrollment
60
Registered
2025-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F489- Nonpsychotic mental disorder, unspecified

Interventions

None listed

Sponsors

Late Kedari Redekar Ayurvedic Mahavidyalaya,Gadhinglaj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient above 20 and below 60 years of age group 2.Patient of both the genders are included 3.Sleep disturbance occurs at least 3 times per week and has been problem for at least 1 month 4. Patient ready to give written informed consent

Exclusion criteria

Exclusion criteria: 1.Patients who are unfit for Abhyanga according to ayurvedic classics 2.Any patients suffering from known systemic illness or any chronic health disorder 3.Patients with Psychiatric diagnosis are excluded from this study were receiving any medication and drug that could cause sedation 4. Pregnant ladies and lactating mothers

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Ksheerabala Taila Shiroabhyanga in the management of Nidranash w.s.r to insomniaTimepoint: On 0th,7th,14th,21st day of trial.

Secondary

MeasureTime frame
1.To study the Nidranash and insomnia according to Ayurveda and modern science respectively in detail, along with mode of action of Shiroabhyanga. 2.To study Ksheerabala Taila in detail.Timepoint: On 0th 7th 14th 21st day of trial.

Countries

India

Contacts

Public ContactDr Tanuja Gaikwad

Late Kedari Redekar Ayurvedic Mahavidyalaya,Gadhinglaj

gaikwadtanuja14@gmail.com7588335343

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026